Description
DrugCard is an AI-driven tool focused on localized literature review for the pharma sector. It helps simplify drug safety procedures and adhere to regulatory standards.
The tool provides consistent and routine monitoring, helping pharmaceutical businesses stay informed about the latest research in their local areas.
It offers traceability and transparency, enabling users to monitor the review process and ensuring it's precise, thorough, and all-encompassing. DrugCard adapts easily to new markets, making it suitable for firms seeking global expansion.
It supports multiple languages and vendors, allowing for a thorough review process. One major benefit of DrugCard is its lack of significant capital expenditure requirements, making it an economical option for pharmaceutical companies.
The platform supports over 100 languages and accesses medical journals from more than 35 countries, delivering broad review coverage. It achieves a high degree of accuracy in scanned PDF analysis. DrugCard is designed for various roles within the pharmaceutical industry, including Contract Research Organizations (CROs), Marketing Authorization Holders (MAHs), and freelancers.
It allows CROs to handle more projects and improve review outcomes, while MAHs have the option to conduct internal reviews to reduce risks related to compliance and reputation.
Freelancers can also leverage the tool to save time on literature reviews and concentrate on other high-value tasks. Overall, DrugCard delivers a dependable and effective solution for localized literature review, equipping the pharmaceutical industry with the necessary tools to simplify drug safety procedures and meet regulatory demands.
